BASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
BASIC CARE ALLERGY (fexofenadine hydrochloride) 180 mg tablets are being recalled nationwide due to failed impurities and product degradation specifications. Approximately 11,904 cartons were affected.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a manufacturing quality failure in an OTC drug. No illnesses or injuries reported. Per the rubric, this is a risk-of-harm product where injury has not yet been reported, warranting High severity.
Plain-English summary
BASIC CARE ALLERGY (fexofenadine hydrochloride) 180 mg tablets are being recalled. The product is sold in 30-count and 150-count cartons under NDCs 72288-847-39, 72288-847-47, and 72288-847-37. The manufacturer is L. Perrigo Company; distribution was conducted by Amazon.com Services LLC.
The recall was initiated because the product failed quality control specifications for impurities and product degradation. The affected lots are: 2GR0329 (expiration 04/24), 2DR0472 (expiration 02/23), and 2MR0417 (expiration 07/24). Approximately 11,904 cartons were distributed nationwide within the USA.
Consumers who purchased this product should stop use. Those with questions are encouraged to contact their healthcare provider or the FDA. Additional information about drug recalls is available at https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls.
The recalled product
- Product
- BASIC CARE ALLERGY (FEXOFENADINE HYDROCHLORIDE)
- Brand
- BASIC CARE ALLERGY
- Manufacturer
- L. Perrigo Company
- Hazard
- Affected units
- 11,904
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot # a) 2GR0329
- Exp. date 04/24 Lot # b) 2DR0472
- Exp. date 02/23
- 2MR0417
- Exp. date 07/24
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by L. Perrigo Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Tablets Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · impurities
See all →- ModerateCipla Recalls Fosfomycin Tromethamine Due to Impurity Specification Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Specifications
FDA (Drugs) · 2026-10-14
- LowMacleods Recalls Olanzapine Tablets Due to Impurity Levels
FDA (Drugs) · 2026-09-30
Similar recalls
- ModerateAmazon Basic+Care Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2022-01-12
- ModeratePerrigo basic+care Fexofenadine Tablets Recall—Failed Impurity Specifications
FDA (Drugs) · 2022-01-12
- ModerateTopCare Allergy Relief Fexofenadine tablets recalled for impurity specifications
FDA (Drugs) · 2022-01-12
- ModerateCAREONE Allergy Relief 180 mg Tablets Recalled for Failed Impurities Specifications
FDA (Drugs) · 2022-01-12
- ModerateFexofenadine Hydrochloride Tablets Recall for Failed Impurity Specifications
FDA (Drugs) · 2022-01-12
- ModerateAmazon Allergy Fexofenadine Hydrochloride Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2022-01-12